Revvity Operating Income 2010-2025 | RVTY

Revvity annual/quarterly operating income history and growth rate from 2010 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  • Revvity operating income for the quarter ending March 31, 2025 was $0.072B, a 63.73% increase year-over-year.
  • Revvity operating income for the twelve months ending March 31, 2025 was $0.375B, a 39.58% increase year-over-year.
  • Revvity annual operating income for 2024 was $0.347B, a 15.36% increase from 2023.
  • Revvity annual operating income for 2023 was $0.301B, a 59.53% decline from 2022.
  • Revvity annual operating income for 2022 was $0.743B, a 40.98% decline from 2021.
Revvity Annual Operating Income
(Millions of US $)
2024 $347
2023 $301
2022 $743
2021 $1,258
2020 $867
2019 $362
2018 $324
2017 $296
2016 $295
2015 $251
2014 $165
2013 $228
2012 $103
2011 $91
2010 $158
2009 $116
Revvity Quarterly Operating Income
(Millions of US $)
2025-03-31 $72
2024-12-31 $119
2024-09-30 $98
2024-06-30 $86
2024-03-31 $44
2023-12-31 $77
2023-09-30 $69
2023-06-30 $78
2023-03-31 $76
2022-12-31 $137
2022-09-30 $111
2022-06-30 $232
2022-03-31 $262
2021-12-31 $263
2021-09-30 $196
2021-06-30 $332
2021-03-31 $468
2020-12-31 $399
2020-09-30 $248
2020-06-30 $176
2020-03-31 $45
2019-12-31 $138
2019-09-30 $79
2019-06-30 $92
2019-03-31 $53
2018-12-31 $116
2018-09-30 $80
2018-06-30 $88
2018-03-31 $40
2017-12-31 $94
2017-09-30 $78
2017-06-30 $74
2017-03-31 $50
2016-12-31 $92
2016-09-30 $76
2016-06-30 $66
2016-03-31 $61
2015-12-31 $50
2015-09-30 $76
2015-06-30 $68
2015-03-31 $57
2014-12-31 $-15
2014-09-30 $59
2014-06-30 $70
2014-03-31 $52
2013-12-31 $94
2013-09-30 $58
2013-06-30 $40
2013-03-31 $36
2012-12-31 $-26
2012-09-30 $43
2012-06-30 $50
2012-03-31 $36
2011-12-31 $-26
2011-09-30 $36
2011-06-30 $39
2011-03-31 $41
2010-12-31 $52
2010-09-30 $41
2010-06-30 $33
2010-03-31 $31
2009-12-31 $31
2009-09-30 $22
2009-06-30 $38
2009-03-31 $25
Sector Industry Market Cap Revenue
Medical Medical Services $10.693B $2.755B
Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $134.596B 25.24
CVS Health (CVS) United States $77.976B 9.69
Elevance Health (ELV) United States $62.251B 8.37
Cencora (COR) United States $56.726B 19.74
DiDi Global (DIDIY) China $26.168B 27.80
Labcorp Holdings (LH) United States $20.342B 16.50
Natera (NTRA) United States $19.203B 0.00
BioMerieux (BMXMF) France $16.276B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $13.895B 0.00
CochLear (CHEOY) Australia $13.050B 0.00
Solventum (SOLV) United States $12.516B 13.25
ICON (ICLR) Ireland $11.276B 10.48
Viatris (VTRS) United States $10.446B 3.59
Medpace Holdings (MEDP) United States $8.878B 22.97
Sonic Healthcare (SKHHY) Australia $8.792B 0.00
Avantor (AVTR) United States $8.409B 12.22
HealthEquity (HQY) United States $8.395B 36.77
Charles River Laboratories (CRL) United States $7.357B 14.42
Caris Life Sciences,�Inc (CAI) United States $7.197B 0.00
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $4.928B 29.02
BrightSpring Health Services (BTSG) United States $3.465B 31.79
Sotera Health (SHC) United States $3.125B 17.76
Surgery Partners (SGRY) United States $2.866B 37.27
Concentras Parent (CON) United States $2.557B 14.78
Alignment Healthcare (ALHC) United States $2.473B 0.00
Organon (OGN) United States $2.457B 2.61
GeneDx Holdings (WGS) United States $2.235B 86.09
Progyny (PGNY) United States $1.966B 43.28
PACS (PACS) United States $1.771B 0.00
Premier (PINC) United States $1.723B 13.08
GoodRx Holdings (GDRX) United States $1.697B 33.93
Ardent Health (ARDT) United States $1.566B 6.68
Teladoc Health (TDOC) United States $1.461B 0.00
Establishment Labs Holdings (ESTA) $1.232B 0.00
Pediatrix Medical (MD) United States $1.086B 8.26
Ryman Healthcare (RYHTY) New Zealand $0.970B 0.00
Agilon Health (AGL) United States $0.886B 0.00
QDM (QDMI) Hong Kong, SAR China $0.846B 290.00
AMN Healthcare Services Inc (AMN) United States $0.711B 6.66
CareDx (CDNA) United States $0.710B 11.09
Nutex Health (NUTX) United States $0.618B 9.35
Embecta (EMBC) United States $0.601B 4.05
So-Young (SY) China $0.581B 0.00
SBC Medicals (SBC) United States $0.541B 0.00
InnovAge Holding (INNV) United States $0.513B 0.00
LifeMD (LFMD) United States $0.474B 0.00
Auna S.A (AUNA) Luxembourg $0.470B 10.58
Sonida Senior Living (SNDA) United States $0.468B 0.00
Omada Health (OMDA) $0.466B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.417B 0.00
Enhabit (EHAB) United States $0.340B 28.00
Oncology Institute (TOI) United States $0.304B 0.00
Performant Healthcare (PHLT) United States $0.295B 0.00
Beauty Health (SKIN) United States $0.209B 0.00
Pheton Holdings (PTHL) China $0.149B 0.00
DocGo (DCGO) United States $0.145B 23.67
Sera Prognostics (SERA) United States $0.110B 0.00
Ascend Wellness Holdings (AAWH) United States $0.081B 0.00
KindlyMD (NAKA) United States $0.066B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
IceCure Medical (ICCM) Israel $0.060B 0.00
Biodesix (BDSX) United States $0.051B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.045B 0.00
Basel Medical Group (BMGL) Singapore $0.043B 0.00
ModivCare (MODV) United States $0.042B 0.00
OSR Holdings (OSRH) United States $0.021B 0.00
Intelligent Bio Solutions (INBS) United States $0.014B 0.00
Co-Diagnostics (CODX) United States $0.010B 0.00
BioNexus Gene Lab (BGLC) $0.009B 0.00
SeaStar Medical Holding (ICU) United States $0.008B 0.00
XWELL (XWEL) United States $0.007B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00